Published in PLoS One on March 19, 2012
Silver nanoparticle protein corona composition in cell culture media. PLoS One (2013) 1.13
Comparison of nanotube-protein corona composition in cell culture media. Small (2013) 1.06
Use of Charged Nanoparticles in NMR-Based Metabolomics for Spectral Simplification and Improved Metabolite Identification. Anal Chem (2015) 0.86
Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches. Int J Nanomedicine (2015) 0.84
The effect of blood protein adsorption on cellular uptake of anatase TiO2 nanoparticles. Int J Nanomedicine (2015) 0.83
A hyperspectral and toxicological analysis of protein corona impact on silver nanoparticle properties, intracellular modifications, and macrophage activation. Int J Nanomedicine (2015) 0.81
Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics. PLoS One (2013) 0.80
Nanomaterials as Non-viral siRNA Delivery Agents for Cancer Therapy. Bioimpacts (2013) 0.80
Understanding protein-nanoparticle interaction: a new gateway to disease therapeutics. Bioconjug Chem (2014) 0.80
Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics. Curr Drug Metab (2013) 0.78
Beyond the passive interactions at the nano-bio interface: evidence of Cu metalloprotein-driven oxidative dissolution of silver nanoparticles. J Nanobiotechnology (2016) 0.75
Current challenges towards in vitro cellular validation of inorganic nanoparticles. Bioconjug Chem (2016) 0.75
Protein corona: a new approach for nanomedicine design. Int J Nanomedicine (2017) 0.75
Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem (2002) 35.30
A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem (2003) 29.58
Mass spectrometry-based proteomics. Nature (2003) 28.94
Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics (2005) 10.60
Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol (2006) 10.14
Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov (2010) 7.48
Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics (2007) 6.96
Quantitative mass spectrometry in proteomics: a critical review. Anal Bioanal Chem (2007) 6.80
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A (2008) 5.76
Immunological properties of engineered nanomaterials. Nat Nanotechnol (2007) 5.59
Quantitative proteomics analysis of the secretory pathway. Cell (2006) 3.63
Beyond chemotherapy: targeted therapies in ovarian cancer. Nat Rev Cancer (2009) 3.46
Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc (2011) 3.19
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev (2009) 3.08
A simplified method to culture human ovarian surface epithelium. Lab Invest (1990) 3.00
Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J Natl Cancer Inst (2004) 2.28
Sensing of proteins in human serum using conjugates of nanoparticles and green fluorescent protein. Nat Chem (2009) 2.19
The evolution of the protein corona around nanoparticles: a test study. ACS Nano (2011) 2.05
Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol (2010) 2.00
Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano (2011) 1.90
Evaluation of nanoparticle immunotoxicity. Nat Nanotechnol (2009) 1.70
The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials (2008) 1.68
A one-step homogeneous immunoassay for cancer biomarker detection using gold nanoparticle probes coupled with dynamic light scattering. J Am Chem Soc (2008) 1.67
A novel four-dimensional strategy combining protein and peptide separation methods enables detection of low-abundance proteins in human plasma and serum proteomes. Proteomics (2005) 1.62
Status of tumor markers in ovarian cancer screening. J Clin Oncol (2003) 1.56
Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology (2009) 1.43
The Vroman effect: a molecular level description of fibrinogen displacement. J Am Chem Soc (2003) 1.41
Monolayer coated gold nanoparticles for delivery applications. Adv Drug Deliv Rev (2011) 1.36
Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development. J Clin Invest (2000) 1.25
Proteomic characterization of engineered nanomaterial-protein interactions in relation to surface reactivity. ACS Nano (2011) 1.24
Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opin Drug Deliv (2011) 1.23
Biological characterization of human epithelial ovarian carcinoma cells in primary culture: the insulin-like growth factor system. Exp Cell Res (1998) 1.22
Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells. Cancer Res (2006) 1.11
Development and molecular characterization of a 2',2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780. Cancer Res (1994) 1.10
Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge. Nanomedicine (2011) 1.02
Contrasting effects of exterior and interior hydrophobic moieties in the complexation of amino acid functionalized gold clusters with alpha-chymotrypsin. Org Lett (2005) 1.01
Cellular uptake of densely packed polymer coatings on gold nanoparticles. ACS Nano (2010) 0.98
Cell biology through proteomics--ad astra per alia porci. Trends Cell Biol (2010) 0.93
Sensitivity improved surface plasmon resonance biosensor for cancer biomarker detection based on plasmonic enhancement. ACS Nano (2011) 0.92
Targeted therapy in ovarian cancer. J Oncol (2010) 0.89
In situ observation of place exchange reactions of gold nanoparticles. Correlation of monolayer structure and stability. Chem Commun (Camb) (2006) 0.87
A facile nanoparticle immunoassay for cancer biomarker discovery. J Nanobiotechnology (2011) 0.86
Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells. Apoptosis (2008) 0.86
Hepatoma-derived growth factor regulates the bad-mediated apoptotic pathway and induction of vascular endothelial growth factor in stomach cancer cells. Oncol Res (2010) 0.84
New frontiers in proteomics research: a perspective. Int J Pharm (2005) 0.84
From the "silent killer" to the "whispering disease": ovarian cancer and the uses of metaphor. Med Hist (2009) 0.82
Gold nanoparticles in delivery applications. Adv Drug Deliv Rev (2008) 4.81
Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem (2004) 3.52
Gold nanoparticles in chemical and biological sensing. Chem Rev (2012) 3.51
Tunable metallic-like conductivity in microbial nanowire networks. Nat Nanotechnol (2011) 2.92
CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model. Nucleic Acids Res (2013) 2.88
Detection and identification of proteins using nanoparticle-fluorescent polymer 'chemical nose' sensors. Nat Nanotechnol (2007) 2.73
Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. J Am Chem Soc (2006) 2.33
Biological properties of "naked" metal nanoparticles. Adv Drug Deliv Rev (2008) 2.33
Magnetic assembly of colloidal superstructures with multipole symmetry. Nature (2009) 2.27
Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res (2008) 2.20
Sensing of proteins in human serum using conjugates of nanoparticles and green fluorescent protein. Nat Chem (2009) 2.19
Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP. J Am Coll Cardiol (2008) 2.04
Detection and differentiation of normal, cancerous, and metastatic cells using nanoparticle-polymer sensor arrays. Proc Natl Acad Sci U S A (2009) 2.02
Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat Nanotechnol (2010) 2.01
Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. Nano Lett (2008) 1.96
Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis. Proc Natl Acad Sci U S A (2010) 1.95
The use of microorganisms for the formation of metal nanoparticles and their application. Appl Microbiol Biotechnol (2005) 1.81
Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. ACS Nano (2008) 1.80
Gold nanoparticle-mediated transfection of mammalian cells. Bioconjug Chem (2002) 1.80
Antiangiogenic properties of gold nanoparticles. Clin Cancer Res (2005) 1.78
Effect of nanoparticle surface charge at the plasma membrane and beyond. Nano Lett (2010) 1.77
Rapid and efficient identification of bacteria using gold-nanoparticle-poly(para-phenyleneethynylene) constructs. Angew Chem Int Ed Engl (2008) 1.71
Photoregulated release of caged anticancer drugs from gold nanoparticles. J Am Chem Soc (2009) 1.68
Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells. J Am Chem Soc (2009) 1.67
Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic. Hypertension (2008) 1.66
Core-controlled polymorphism in virus-like particles. Proc Natl Acad Sci U S A (2007) 1.66
MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res (2009) 1.64
Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles. J Exp Ther Oncol (2008) 1.59
Biomimetic interactions of proteins with functionalized nanoparticles: a thermodynamic study. J Am Chem Soc (2007) 1.58
Nanoparticle hydrophobicity dictates immune response. J Am Chem Soc (2012) 1.57
Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells. J Nanobiotechnology (2008) 1.56
Endothelial cell-specific chemotaxis receptor (ecscr) promotes angioblast migration during vasculogenesis and enhances VEGF receptor sensitivity. Blood (2010) 1.55
Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev (2012) 1.55
Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev (2009) 1.54
Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J Control Release (2010) 1.54
Functionalized gold nanoparticles for drug delivery. Nanomedicine (Lond) (2007) 1.53
Tunable inhibition and denaturation of alpha-chymotrypsin with amino acid-functionalized gold nanoparticles. J Am Chem Soc (2005) 1.53
Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles. PLoS One (2011) 1.53
Revealing the role of phospholipase Cβ3 in the regulation of VEGF-induced vascular permeability. Blood (2012) 1.51
Light-regulated release of DNA and its delivery to nuclei by means of photolabile gold nanoparticles. Angew Chem Int Ed Engl (2006) 1.45
Identification of potential protein interactors of Lrrk2. Parkinsonism Relat Disord (2007) 1.44
The role of surface functionality on acute cytotoxicity, ROS generation and DNA damage by cationic gold nanoparticles. Small (2010) 1.43
Nano meets biology: structure and function at the nanoparticle interface. Langmuir (2011) 1.43
Enzyme-amplified array sensing of proteins in solution and in biofluids. J Am Chem Soc (2010) 1.41
Protein-passivated Fe(3)O(4) nanoparticles: low toxicity and rapid heating for thermal therapy. J Mater Chem (2008) 1.39
Surface functionalization of nanoparticles for nanomedicine. Chem Soc Rev (2012) 1.38
Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis. J Nanobiotechnology (2007) 1.37
Regulatory role of dynamin-2 in VEGFR-2/KDR-mediated endothelial signaling. FASEB J (2005) 1.37
Control of protein structure and function through surface recognition by tailored nanoparticle scaffolds. J Am Chem Soc (2004) 1.36
Monolayer coated gold nanoparticles for delivery applications. Adv Drug Deliv Rev (2011) 1.36
Role of hedgehog signaling in ovarian cancer. Clin Cancer Res (2008) 1.36
Multiplexed screening of cellular uptake of gold nanoparticles using laser desorption/ionization mass spectrometry. J Am Chem Soc (2008) 1.34
Nanoparticle-templated assembly of viral protein cages. Nano Lett (2006) 1.33
CrossMap: a versatile tool for coordinate conversion between genome assemblies. Bioinformatics (2013) 1.33
Gold nanoparticles: preparation, properties, and applications in bionanotechnology. Nanoscale (2011) 1.32
Gold nanoparticles: opportunities and challenges in nanomedicine. Expert Opin Drug Deliv (2010) 1.32
Quantum dot encapsulation in viral capsids. Nano Lett (2006) 1.31
Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2. J Biol Chem (2005) 1.31
Recognition-mediated activation of therapeutic gold nanoparticles inside living cells. Nat Chem (2010) 1.29
Enzyme mediated extracellular synthesis of CdS nanoparticles by the fungus, Fusarium oxysporum. J Am Chem Soc (2002) 1.26
Proteomic analysis of mantle-cell lymphoma by protein microarray. Blood (2005) 1.23
Stability of quantum dots in live cells. Nat Chem (2011) 1.22
Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6. Blood (2010) 1.21
Calculating sample size estimates for RNA sequencing data. J Comput Biol (2013) 1.21
Array-based sensing with nanoparticles: 'chemical noses' for sensing biomolecules and cell surfaces. Curr Opin Chem Biol (2010) 1.20
Inhibition of chymotrypsin through surface binding using nanoparticle-based receptors. Proc Natl Acad Sci U S A (2002) 1.19
Polymer and biopolymer mediated self-assembly of gold nanoparticles. Chem Soc Rev (2008) 1.18
The role of surface functionality in determining nanoparticle cytotoxicity. Acc Chem Res (2013) 1.17
Surface properties dictate uptake, distribution, excretion, and toxicity of nanoparticles in fish. Small (2010) 1.16
Gold nanoparticle-fluorophore complexes: sensitive and discerning "noses" for biosystems sensing. Angew Chem Int Ed Engl (2010) 1.16
Colorimetric bacteria sensing using a supramolecular enzyme-nanoparticle biosensor. J Am Chem Soc (2011) 1.16
Towards an in vivo biologically inspired nanofactory. Nat Nanotechnol (2007) 1.15
CAP-miRSeq: a comprehensive analysis pipeline for microRNA sequencing data. BMC Genomics (2014) 1.15
Engineering the nanoparticle-protein interface: applications and possibilities. Curr Opin Chem Biol (2010) 1.12
Role of surface charge density in nanoparticle-templated assembly of bromovirus protein cages. ACS Nano (2010) 1.12
Intracellular delivery of a membrane-impermeable enzyme in active form using functionalized gold nanoparticles. J Am Chem Soc (2010) 1.12
Tunable reactivation of nanoparticle-inhibited beta-galactosidase by glutathione at intracellular concentrations. J Am Chem Soc (2004) 1.11
Stability of gold nanoparticle-bound DNA toward biological, physical, and chemical agents. Chem Biol Drug Des (2006) 1.11